Friday, July 10, 2026
🇺🇸 FDA

pharma · Generalized Myasthenia Gravis · Chronic inflammatory demyelinating polyneuropathy (CIDP)

Argenx

argenx

Argenx trial registry — 32 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
33 Arch Street, Suite 3201, Boston, MA 02110, US HQ
2008 Founded
2,179 Employees
NMPA registrant Type
Company details
Status
Public
HQ
33 Arch Street, Suite 3201, Boston, MA 02110, US
Founded
2008
Employees
2,179
Programs
32
Drugs
16
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Argenx clinical trials

Registry index of 32 ClinicalTrials.gov studies linked to Argenx programs — each row shows trial ID, program name, phase, status, and indication.

Argenx trial registry — 32 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Argenx.

  1. ARGX-119-2303 — Phase 2

    Clinical update

  2. ARGX-117-2402 — Phase 3

    Clinical update

  3. ARGX-117-2301 — Phase 2

    Clinical update

  4. ARGX-113-2405 — Phase 1

    Clinical update

  5. ARGX-113-2315 — Phase 3

    Clinical update

  6. ARGX-113-2007 — Phase 3

    Clinical update

  7. ARGX-117-2003 — Phase 2

    Clinical update

  8. ARGX-113-2009 — Phase 3

    Clinical update

Trial registry

32 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.